The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time.
In Tuesday's Report: Moderna announces vaccine efficacy, Fauci concerned about presidential transition, testing labs raise supply chain alarm, impact of COVID-19 on insolvency and arbitration in the U.K., and a podcast on IVDs being granted FDA EUAs.
Tuesday, 17 November 2020
-
In the latest episode of our "Talking the Cure" Podcast, Randy J. Prebula, Susan D. Tiedy-Stevenson, and Erkang Ai, Ph.D. discuss the world of in vitro diagnostics (IVD), the current SARS-CoV-2 situation, and the various IVDs that are being granted Emergency Use Authorization by the U.S. Food and Drug Administration (FDA).
-
The Hogan Lovells Government Relations and Public Affairs group is tracking all of the latest developments in the U.S. Congress and relevant news stories. On Monday, Moderna announced that its coronavirus is 94.5% effective against COVID-19 in its phase three testing. NIH official Dr. Anthony Fauci told NBC’s Today Show on Monday said that he's "concerned" about the stalled transition process between President Trump and President-elect Biden. Fauci specifically highlighted the need for a "smooth process" for approving and distributing a COVID-19 vaccine. More than 16 GOP governors rejected President-elect Joe Biden’s suggested statewide mask mandates in order to curb the pandemic, even though their states are seeing a massive surge in new outbreaks and despite new CDC guidance emphasizing the importance of masks for both wearer and surrounding people. Testing labs processing COVID-19 tests are concerned that there will be a delay in testing and supply chain shortages as the U.S. continues to see a mounting number of cases. Read about these and other updates here: 16 Nov.; 13 Nov.; 12 Nov. (Authored by Ivan Zapien)
-
In an article for Lexis®PSL, Duncan Gorst and Josh Redman discuss the relationship between insolvency and arbitration. They consider the impact coronavirus has had on insolvency and arbitration as well as issues parties should consider when bringing arbitration proceedings against parties at risk of insolvency. The analysis focuses on arbitrations subject to the law of England and Wales, and, unless stated, with an English seat.
[View source.]
